Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neurobiology of Aging

• Publication date

  2014-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2014.07.022PMID 25155093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.

  2014cited by this paper
• Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.

  2013cited by this paper
• ALS and Frontotemporal Dysfunction: A Review

  2012cited by this paper
• Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

  2011cited by this paper
• A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

  2011cited by this paper
• Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

  2011cited by this paper
• Protein structure prediction on the Web: a case study using the Phyre server

  2009cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic

  1994cited by this paper
• El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis

  1994cited by this paper
• Clinical limits of amyotrophic lateral sclerosis.

  1982cited by this paper

• SLP2/PHB Aggregates in ALS Mouse Models and Patients: Implications Beyond CHCHD10-Associated Motor Neuron Disease

  2025cites this paper
• Dose-dependent CHCHD10 dysregulation dictates motor neuron disease severity and alters creatine metabolism

  2025cites this paper
• Transcriptome-based screening in TARDBP/TDP-43 knock-in motor neurons identifies the NEDD8-activating enzyme inhibitor MLN4924

  2024cites this paper
• CHCHD10S59L/+ mouse model: Behavioral and neuropathological features of frontotemporal dementia.

  2024cites this paper
• Nifuroxazide rescues the deleterious effects due to CHCHD10-associated MICOS defects in disease models.

  2024cites this paper
• Dégénérescences lobaires frontotemporales : neuropathologie, génétique et classification

  2024cites this paper
• Degenerazioni lobari frontotemporali: neuropatologia, genetica e classificazione

  2024cites this paper
• Skeletal muscle in amyotrophic lateral sclerosis

  2023cites this paper
• Advances in sequencing technologies for amyotrophic lateral sclerosis research

  2023cites this paper
• Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion

  2023cites this paper
• Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis

  2023cites this paper
• Definitions, phenomenology, diagnosis, and management of the disorders of laughter and crying in amyotrophic lateral sclerosis (ALS): Consensus from ALS and Motor Neuron Disease Scientific Department of the Brazilian Academy of Neurology

  2023cites this paper
• Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants

  2023cites this paper
• CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response

  2022cites this paper
• Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10–what distinguishes the two?

  2022cites this paper
• Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease

  2022cites this paper
• Semantic and right temporal variant of FTD: Next generation sequencing genetic analysis on a single-center cohort

  2022cites this paper
• TDP-43 and PINK1 mediate CHCHD10S59L mutation–induced defects in Drosophila and in vitro

  2021cites this paper
• Genetic architecture of motor neuron diseases.

  2021cites this paper
• Mouse midbrain dopaminergic neurons survive loss of the PD-associated mitochondrial protein CHCHD2.

  2021cites this paper
• The mitochondrial intermembrane space: the most constricted mitochondrial sub-compartment with the largest variety of protein import pathways

  2021cites this paper
• Multi-OMICS study of a CHCHD10 variant causing ALS demonstrates metabolic rewiring and activation of endoplasmic reticulum and mitochondrial unfolded protein responses.

  2021cites this paper
• Genetics of frontotemporal dementia in China

  2021cites this paper
• Regulation of COX Assembly and Function by Twin CX9C Proteins—Implications for Human Disease

  2021cites this paper
• Neuropathologic description of CHCHD10 mutated amyotrophic lateral sclerosis

  2020cites this paper
• Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications

  2020cites this paper
• Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

  2020cites this paper
• The Maintenance of Mitochondrial DNA Integrity and Dynamics by Mitochondrial Membranes

  2020cites this paper
• Meta-analysis of the association between CHCHD10 Pro34Ser variant and the risk of amyotrophic lateral sclerosis

  2020cites this paper
• A CHCHD10 variant causing ALS elicits an unfolded protein response through the IRE1/XBP1 pathway

  2020cites this paper
• Mitochondrial retrograde signalling in neurological disease

  2020cites this paper
• Genetic forms of frontotemporal lobar degeneration: Current diagnostic approach and new directions in therapeutic strategies.

  2020cites this paper
• The MICOS complex, a structural element of mitochondria with versatile functions

  2020cites this paper
• The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  2020cites this paper
• Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice

  2019cites this paper
• ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?

  2019cites this paper
• Génétique de la sclérose latérale amyotrophique

  2019cites this paper
• Dominant toxicity of ALS–FTD-associated CHCHD10S59L is mediated by TDP-43 and PINK1

  2019cites this paper
• Genetica della sclerosi laterale amiotrofica

  2019cites this paper
• Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review

  2019cites this paper
• Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia

  2019cites this paper
• Single-cell transcriptomes reveal molecular specializations of neuronal cell types in the developing cerebellum

  2019cites this paper
• Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral Sclerosis.

  2019cites this paper
• Lysosomal Dysfunction at the Centre of Parkinson's Disease and Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.

  2019cites this paper
• [A case of mitochondrial disease with multiple mitochondrial DNA deletions suspected amyotrophic lateral sclerosis-frontotemporal dementia].

  2018cites this paper
• Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications.

  2018cites this paper
• Mortal engines: Mitochondrial bioenergetics and dysfunction in neurodegenerative diseases.

  2018cites this paper
• PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction

  2018cites this paper
• Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.

  2018cites this paper
• CHCHD10 variants in amyotrophic lateral sclerosis: Where is the evidence?

  2018cites this paper
• Frontotemporal dementia.

  2018cites this paper
• ALS Genes in the Genomic Era and their Implications for FTD.

  2018cites this paper
• A novel CHCHD10 mutation implicates a Mia40‐dependent mitochondrial import deficit in ALS

  2018cites this paper
• Chchd10, A Novel Bi-Organellar Regulator Of Cellular Metabolism: Implications In Neurodegeneration

  2018cites this paper
• The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction

  2018cites this paper
• Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis.

  2018cites this paper
• Genetics of Amyotrophic Lateral Sclerosis.

  2018cites this paper
• Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.

  2017cites this paper
• Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene

  2017cites this paper
• Genetics of amyotrophic lateral sclerosis.

  2017cites this paper
• Familial Early-Onset Paget’s Disease of Bone Associated with a Novel hnRNPA2B1 Mutation

  2017cites this paper
• TREM2 in Neurodegenerative Diseases

  2017cites this paper
• Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer's disease.

  2017cites this paper
• Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression

  2017cites this paper
• Erratum to: Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases

  2017cites this paper
• Neurodegeneration-associated mutant TREM2 proteins abortively cycle between the ER and ER–Golgi intermediate compartment

  2017cites this paper
• Genetic Features of MAPT, GRN, C9orf72 and CHCHD10 Gene Mutations in Chinese Patients with Frontotemporal Dementia.

  2017cites this paper
• MNRR1, a Biorganellar Regulator of Mitochondria

  2017cites this paper
• Soluble TREM2 induces inflammatory responses and enhances microglial survival

  2017cites this paper
• Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases

  2017cites this paper
• Epilepsy at the prodromal stages of neurodegenerative diseases.

  2017cites this paper
• Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients.

  2017influential citation
• Epilepsy and electroencephalographic abnormalities in C9orf72 repeat expansion

  2017cites this paper
• Fungal infection in neural tissue of patients with amyotrophic lateral sclerosis.

  2017cites this paper
• Intrafamilial clinical variability in individuals carrying the CHCHD10 mutation Gly66Val

  2016cites this paper
• The 'Omics' of Amyotrophic Lateral Sclerosis.

  2016cites this paper
• Screening for CHCHD10 mutations in a large cohort of sporadic ALS patients: no evidence for pathogenicity of the p.P34S variant.

  2016influential citation
• Reply: High prevalence of CHCHD10 mutations in patients with frontotemporal dementia from China.

  2016cites this paper
• Mitochondrial Proteins Containing Coiled-Coil-Helix-Coiled-Coil-Helix (CHCH) Domains in Health and Disease.

  2016cites this paper
• Genetic analysis of CHCHD10 in French familial amyotrophic lateral sclerosis patients.

  2016cites this paper
• Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic

  2016cites this paper
• New ALS‐Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis

  2016cites this paper
• Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases

  2016cites this paper
• Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies

  2016cites this paper
• Genetics of FTLD: overview and what else we can expect from genetic studies

  2016cites this paper
• CHCHD 10 Pro 34 Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia

  2016cites this paper
• High prevalence of CHCHD10 mutation in patients with frontotemporal dementia from China.

  2016cites this paper
• LETTER TO THE EDITOR CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia

  2016cites this paper
• Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians

  2016cites this paper
• Amyotrophic lateral sclerosis: recent genetic highlights.

  2016cites this paper
• CHCHD10 mutations and motor neuron disease: the distribution in Finnish patients

  2016cites this paper
• CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia.

  2016cites this paper
• Identification of CHCHD10 Mutation in Chinese Patients with Alzheimer Disease

  2016cites this paper
• ALS: Recent Developments from Genetics Studies

  2016cites this paper
• Impaired Autophagy and Defective Mitochondrial Function: Converging Paths on the Road to Motor Neuron Degeneration

  2016cites this paper
• 1 Mitochondrial proteins containing coiled-coil-helix-coiled-coil-helix ( CHCH ) domains in health and disease

  2016cites this paper
• CHCHD10 is not a frequent causative gene in Chinese ALS patients

  2016cites this paper
• Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis

  2016cites this paper
• Amyotrophic Lateral Sclerosis 1 and Many Diseases

  2016cites this paper
• Late-onset spinal motor neuronopathy- a new neuromuscular disease

  2015cites this paper